Dr. Ursa A. Brown-Glaberman
Claim this profileUniversity of New Mexico Cancer Center
Studies Breast Cancer
Studies Skin Cancer
20 reported clinical trials
45 drugs studied
About Ursa A. Brown-Glaberman
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Serves as an Associate Professor in the Department of Internal Medicine, Division of Hematology/Oncology, at the UNM School of Medicine.
- Holds the position of Medical Director for Clinical Research at the University of New Mexico Comprehensive Cancer Center (UNMCCC).
- Specializes in the treatment of breast and gastrointestinal cancers.
- Awarded the National Cancer Institute's Cancer Clinical Investigator Team Leadership Award in 2017.
- Leads both the Breast and Gastrointestinal Cancer Programs at UNMCCC.
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
Stage III
2Skin Cancer
Stage IV
HER2 positive
HER2 negative
Affiliated Hospitals
Clinical Trials Ursa A. Brown-Glaberman is currently running
Digital Tomosynthesis vs. Standard Mammography
for Breast Cancer Screening
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Recruiting2 awards Phase 34 criteria
Pre- and Post-Surgery Chemotherapy
for Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller; therefore, may reduce the extent of surgery. Additionally, it may make it easier for the surgeon to distinguish between normal and cancerous tissue. Giving chemotherapy after surgery may kill any remaining tumor cells. This study will determine whether giving chemotherapy before surgery increases the length of time before the cancer may return and whether it will increase a patient's life span compared to the usual approach.
Recruiting1 award Phase 2 & 315 criteria
More about Ursa A. Brown-Glaberman
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Ursa A. Brown-Glaberman has experience with
- Cisplatin
- Pembrolizumab
- Palbociclib
- Fluorouracil
- Gemcitabine
- Gemcitabine Hydrochloride
Breakdown of trials Ursa A. Brown-Glaberman has run
Breast Cancer
Skin Cancer
Gallbladder Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ursa A. Brown-Glaberman specialize in?
Ursa A. Brown-Glaberman focuses on Breast Cancer and Skin Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Ursa A. Brown-Glaberman currently recruiting for clinical trials?
Yes, Ursa A. Brown-Glaberman is currently recruiting for 9 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Ursa A. Brown-Glaberman has studied deeply?
Yes, Ursa A. Brown-Glaberman has studied treatments such as Cisplatin, Pembrolizumab, Palbociclib.
What is the best way to schedule an appointment with Ursa A. Brown-Glaberman?
Apply for one of the trials that Ursa A. Brown-Glaberman is conducting.
What is the office address of Ursa A. Brown-Glaberman?
The office of Ursa A. Brown-Glaberman is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87131 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.